Anmeldung erfolgt in Kürze...
Details werden geladen...
Moderna cancer vaccine: mRNA treatment trial reduces risk of melanoma recurrence and spread
Moderna and Merck said the personalised vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment.
Ähnliche Seiten
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.brisbanetimes.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html?ref=rss&utm_medium=rss&utm_source=rss_feed
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.smh.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.theage.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html?ref=rss&utm_medium=rss&utm_source=rss_feed
Moderna and Merck cancer vaccine: Trial shows mRNA treatment reduces risk of melanoma recurrence and spread
https://www.watoday.com.au/world/north-america/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html?ref=rss&utm_medium=rss&utm_source=rss_feed
Moderna cancer vaccine trial: Shares jump 177% after melanoma breakthrough - India Today
https://www.indiatoday.in/business/companies/story/moderna-cancer-vaccine-trial-shares-jump-177-after-melanoma-breakthrough-2975432-2026-08-20